Ninon Burgos1,2,3,4,5, M Jorge Cardoso6, Jorge Samper-González1,2,3,4,5, Marie-Odile Habert7,8,9, Stanley Durrleman1,2,3,4,5, Sébastien Ourselin6, Olivier Colliot1,2,3,4,5. 1. Paris Brain Institute, Hôpital Pitié-Salpêtrière, Paris, France. 2. INSERM, U 1127, Hôpital Pitié-Salpêtrière, Paris, France. 3. CNRS, UMR 7225, Hôpital Pitié-Salpêtrière, Paris, France. 4. Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France. 5. Inria, Aramis Project-Team, Hôpital Pitié-Salpêtrière, Paris, France. 6. King's College London, Department of Imaging and Biomedical Engineering, London, United Kingdom. 7. AP-HP, Hôpital Pitié-Salpêtrière, Department of Nuclear Medicine, Paris, France. 8. Laboratoire d'Imagerie Biomédicale, Sorbonne Université, Inserm U 1146, CNRS UMR 7371, Hôpital Pitié-Salpêtrière, Paris, France. 9. Centre Acquisition et Traitement des Images, Hôpital Pitié-Salpêtrière, Paris, France.
Abstract
Purpose: In clinical practice, positron emission tomography (PET) images are mostly analyzed visually, but the sensitivity and specificity of this approach greatly depend on the observer's experience. Quantitative analysis of PET images would alleviate this problem by helping define an objective limit between normal and pathological findings. We present an anomaly detection framework for the individual analysis of PET images. Approach: We created subject-specific abnormality maps that summarize the pathology's topographical distribution in the brain by comparing the subject's PET image to a model of healthy PET appearance that is specific to the subject under investigation. This model was generated from demographically and morphologically matched PET scans from a control dataset. Results: We generated abnormality maps for healthy controls, patients at different stages of Alzheimer's disease and with different frontotemporal dementia syndromes. We showed that no anomalies were detected for the healthy controls and that the anomalies detected from the patients with dementia coincided with the regions where abnormal uptake was expected. We also validated the proposed framework using the abnormality maps as inputs of a classifier and obtained higher classification accuracies than when using the PET images themselves as inputs. Conclusions: The proposed method was able to automatically locate and characterize the areas characteristic of dementia from PET images. The abnormality maps are expected to (i) help clinicians in their diagnosis by highlighting, in a data-driven fashion, the pathological areas, and (ii) improve the interpretability of subsequent analyses, such as computer-aided diagnosis or spatiotemporal modeling.
Purpose: In clinical practice, positron emission tomography (PET) images are mostly analyzed visually, but the sensitivity and specificity of this approach greatly depend on the observer's experience. Quantitative analysis of PET images would alleviate this problem by helping define an objective limit between normal and pathological findings. We present an anomaly detection framework for the individual analysis of PET images. Approach: We created subject-specific abnormality maps that summarize the pathology's topographical distribution in the brain by comparing the subject's PET image to a model of healthy PET appearance that is specific to the subject under investigation. This model was generated from demographically and morphologically matched PET scans from a control dataset. Results: We generated abnormality maps for healthy controls, patients at different stages of Alzheimer's disease and with different frontotemporal dementia syndromes. We showed that no anomalies were detected for the healthy controls and that the anomalies detected from the patients with dementia coincided with the regions where abnormal uptake was expected. We also validated the proposed framework using the abnormality maps as inputs of a classifier and obtained higher classification accuracies than when using the PET images themselves as inputs. Conclusions: The proposed method was able to automatically locate and characterize the areas characteristic of dementia from PET images. The abnormality maps are expected to (i) help clinicians in their diagnosis by highlighting, in a data-driven fashion, the pathological areas, and (ii) improve the interpretability of subsequent analyses, such as computer-aided diagnosis or spatiotemporal modeling.
Authors: Marc Modat; David M Cash; Pankaj Daga; Gavin P Winston; John S Duncan; Sébastien Ourselin Journal: J Med Imaging (Bellingham) Date: 2014-09-19
Authors: Chloe Hutton; Jerome Declerck; Mark A Mintun; Michael J Pontecorvo; Michael D Devous; Abhinay D Joshi Journal: Eur J Nucl Med Mol Imaging Date: 2015-02-05 Impact factor: 9.236
Authors: Lisa Mosconi; Wai H Tsui; Karl Herholz; Alberto Pupi; Alexander Drzezga; Giovanni Lucignani; Eric M Reiman; Vjera Holthoff; Elke Kalbe; Sandro Sorbi; Janine Diehl-Schmid; Robert Perneczky; Francesca Clerici; Richard Caselli; Bettina Beuthien-Baumann; Alexander Kurz; Satoshi Minoshima; Mony J de Leon Journal: J Nucl Med Date: 2008-02-20 Impact factor: 10.057
Authors: Thomas Schlegl; Philipp Seeböck; Sebastian M Waldstein; Georg Langs; Ursula Schmidt-Erfurth Journal: Med Image Anal Date: 2019-01-31 Impact factor: 8.545
Authors: R C Petersen; P S Aisen; L A Beckett; M C Donohue; A C Gamst; D J Harvey; C R Jack; W J Jagust; L M Shaw; A W Toga; J Q Trojanowski; M W Weiner Journal: Neurology Date: 2009-12-30 Impact factor: 9.910
Authors: M Signorini; E Paulesu; K Friston; D Perani; A Colleluori; G Lucignani; F Grassi; V Bettinardi; R S Frackowiak; F Fazio Journal: Neuroimage Date: 1999-01 Impact factor: 6.556
Authors: Ninon Burgos; M Jorge Cardoso; Kris Thielemans; Marc Modat; Stefano Pedemonte; John Dickson; Anna Barnes; Rebekah Ahmed; Colin J Mahoney; Jonathan M Schott; John S Duncan; David Atkinson; Simon R Arridge; Brian F Hutton; Sebastien Ourselin Journal: IEEE Trans Med Imaging Date: 2014-07-17 Impact factor: 10.048